Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Sherman

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenJason T Blackard, Jeffrey A Welge, Lynn E Taylor, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2009
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive womenPeter D Dryer, Berkeley N Limketkai, Christina M Martin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Kenneth E Sherman, Janet W Andersen, Adeel A Butt, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 5, 2007
Viral factors associated with cytokine expression during HCV/HIV co-infectionJason T Blackard, Minhee Kang, J Benjamin St Clair, et al.
Drug and Alcohol Dependence|January 16, 2022
Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIVJavier A Tamargo, Kenneth E Sherman, Rafick-Pierre Sékaly, et al.
World Journal of Hepatology|February 21, 2017
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfectionKenneth E Sherman, Minhee Kang, Richard Sterling, et al.
JAMA Internal Medicine|December 9, 2014
Liver fibrosis progression in hepatitis C virus infection after seroconversionAdeel A Butt, Peng Yan, Vincent Lo Re, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic BlockadeKenneth E Sherman, Enass Abdel-Hameed, Susan D Rouster, et al.
Pathogens & Immunity|August 13, 2024
Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV CoinfectionKenneth E Sherman, Susan D Rouster, Heidi Meeds, et al.
The American Journal of Clinical Nutrition|January 30, 2021
Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIVJavier A Tamargo, Kenneth E Sherman, Adriana Campa, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenJason T Blackard, Jeffrey A Welge, Lynn E Taylor, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2009
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive womenPeter D Dryer, Berkeley N Limketkai, Christina M Martin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Kenneth E Sherman, Janet W Andersen, Adeel A Butt, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 5, 2007
Viral factors associated with cytokine expression during HCV/HIV co-infectionJason T Blackard, Minhee Kang, J Benjamin St Clair, et al.
Drug and Alcohol Dependence|January 16, 2022
Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIVJavier A Tamargo, Kenneth E Sherman, Rafick-Pierre Sékaly, et al.
World Journal of Hepatology|February 21, 2017
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfectionKenneth E Sherman, Minhee Kang, Richard Sterling, et al.
JAMA Internal Medicine|December 9, 2014
Liver fibrosis progression in hepatitis C virus infection after seroconversionAdeel A Butt, Peng Yan, Vincent Lo Re, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic BlockadeKenneth E Sherman, Enass Abdel-Hameed, Susan D Rouster, et al.
Pathogens & Immunity|August 13, 2024
Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV CoinfectionKenneth E Sherman, Susan D Rouster, Heidi Meeds, et al.
The American Journal of Clinical Nutrition|January 30, 2021
Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIVJavier A Tamargo, Kenneth E Sherman, Adriana Campa, et al.
Pageof 22